Head-To-Head Survey: Inari Medical (NASDAQ:NARI) & Biotricity (NASDAQ:BTCY)

Biotricity (NASDAQ:BTCY) and Inari Medical (NASDAQ:NARI) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, analyst recommendations, institutional ownership and earnings.

Institutional and Insider Ownership

3.9% of Biotricity shares are held by institutional investors. Comparatively, 91.0% of Inari Medical shares are held by institutional investors. 20.5% of Biotricity shares are held by insiders. Comparatively, 10.6% of Inari Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Earnings and Valuation

This table compares Biotricity and Inari Medical’s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biotricity	$9.64 million	1.21	-$18.66 million	($1.39)	-0.89
Inari Medical	$493.63 million	5.61	-$1.64 million	($0.41)	-116.27

Inari Medical has higher revenue and earnings than Biotricity. Inari Medical is trading at a lower price-to-earnings ratio than Biotricity, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Biotricity and Inari Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Biotricity	-125.43%	N/A	-233.67%
Inari Medical	-4.54%	-1.65%	-1.23%

Analyst Ratings

This is a summary of recent recommendations and price targets for Biotricity and Inari Medical, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biotricity	0	1	0	0	2.00
Inari Medical	0	2	5	0	2.71

Inari Medical has a consensus target price of $65.71, suggesting a potential upside of 37.85%. Given Inari Medical’s stronger consensus rating and higher probable upside, analysts plainly believe Inari Medical is more favorable than Biotricity.

Risk & Volatility

Biotricity has a beta of 1.54, suggesting that its share price is 54% more volatile than the S&P 500. Comparatively, Inari Medical has a beta of 0.93, suggesting that its share price is 7% less volatile than the S&P 500.

Summary

Inari Medical beats Biotricity on 10 of the 14 factors compared between the two stocks.

About Biotricity

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

About Inari Medical

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.